frcpc

Pick anything below and it plays in the bar at the foot of the window — and keeps playing while you go on browsing the directory.

1. 1▶Raj Chovatiya, MD, PhD, MSCI - In Your Hands: A Case-Based Approach to Treating Moderate-to-Severe Chronic Hand EczemaPeerVoice Endocrinology & Metabolic Disorders Video23:38Notes
   +Watch later
2. 2▶Amarnath Challapalli, MBBS, MD (RT), MRCP, FRCR, PhD, FRCP / Amer Durrani, FRCS (Plast) - Partnering With Patients in High-Risk CSCC: Redefining the Surgical Paradigm to Optimise Clinical and Patient OutcomesPeerVoice Oncology & Haematology Video32:12Notes
   +Watch later
3. 3▶Luis Querol, MD, PhD - CIDP at a Crossroads: Addressing the Burden of Suboptimal Care and the Need for Therapeutic AdvancementPeerVoice Clinical Pharmacology Video19:20Notes
   +Watch later
4. 4▶Amarnath Challapalli, MBBS, MD (RT), MRCP, FRCR, PhD, FRCP / Amer Durrani, FRCS (Plast) - Partnering With Patients in High-Risk CSCC: Redefining the Surgical Paradigm to Optimise Clinical and Patient OutcomesPeerVoice Clinical Pharmacology Video32:12Notes
   +Watch later
5. 5▶Luis Querol, MD, PhD - CIDP at a Crossroads: Addressing the Burden of Suboptimal Care and the Need for Therapeutic AdvancementPeerVoice Brain & Behaviour Audio19:20Notes
   +Listen later
6. 6▶Luis Querol, MD, PhD - CIDP at a Crossroads: Addressing the Burden of Suboptimal Care and the Need for Therapeutic AdvancementPeerVoice Brain & Behaviour Video19:20Notes
   +Watch later
7. 7▶Meletios Dimopoulos, MD - Individualisation Requires Communication: Working With Our Patients With Newly Diagnosed Multiple Myeloma (NDMM) to Optimise Treatment OutcomesPeerVoice Oncology & Haematology Video1:20:49Notes
   +Watch later
8. 8▶One Disease, Many Clinical Presentations: Why and How to Spot Acute Hepatic Porphyria in Different Healthcare SettingsPeerVoice Oncology & Haematology Video26:33Notes
   +Watch later
9. 9▶One Disease, Many Clinical Presentations: Why and How to Spot Acute Hepatic Porphyria in Different Healthcare SettingsPeerVoice Clinical Pharmacology Video26:33Notes
   +Watch later
10. 10▶John Friedewald, MD, FASN, FAST - Breakthroughs and Buzz From Boston: Key Takeaways for the Kidney Transplant CommunityPeerVoice Clinical Pharmacology Video17:39Notes
    +Watch later
11. 11▶Kausik Ray, MD, MPhil (Cantab), FMedSci - Altering the Disease Trajectory in Patients With and at High Risk of Atherosclerotic Cardiovascular Disease: Ensuring Best Practices for Identification and ManagementPeerVoice Clinical Pharmacology Video16:39Notes
    +Watch later
12. 12▶One Disease, Many Clinical Presentations: Why and How to Spot Acute Hepatic Porphyria in Different Healthcare SettingsPeerVoice Brain & Behaviour Audio26:33Notes
    +Listen later
13. 13▶Kausik Ray, MD, MPhil (Cantab), FMedSci - Altering the Disease Trajectory in Patients With and at High Risk of Atherosclerotic Cardiovascular Disease: Ensuring Best Practices for Identification and ManagementPeerVoice Heart & Lung Video16:39Notes
    +Watch later
14. 14▶One Disease, Many Clinical Presentations: Why and How to Spot Acute Hepatic Porphyria in Different Healthcare SettingsPeerVoice Brain & Behaviour Video26:33Notes
    +Watch later
15. 15▶Carel le Roux, MBChB, MSc, PhD - Beyond BMI: Transforming Modern Weight Management for Heart, Kidney, and Metabolic HealthPeerVoice Endocrinology & Metabolic Disorders Video1:17:14Notes
    +Watch later
16. 16▶Carel le Roux, MBChB, MSc, PhD - Beyond BMI: Transforming Modern Weight Management for Heart, Kidney, and Metabolic HealthPeerVoice Clinical Pharmacology Video1:17:14Notes
    +Watch later
17. 17▶Carel le Roux, MBChB, MSc, PhD - Beyond BMI: Transforming Modern Weight Management for Heart, Kidney, and Metabolic HealthPeerVoice Heart & Lung Video1:17:14Notes
    +Watch later
18. 18▶Hannele Yki-Järvinen, MD, FRCP - MASH Matters – and It’s More Than Just a Metabolic DiseasePeerVoice Endocrinology & Metabolic Disorders Video25:41Notes
    +Watch later
19. 19▶Andrea Necchi, MD - Working With Our Patients as a Member of the MDT: A Bladder Cancer Awareness Month 2026 CME InitiativePeerVoice Oncology & Haematology Video21:06Notes
    +Watch later
20. 20▶Hannele Yki-Järvinen, MD, FRCP - MASH Matters – and It’s More Than Just a Metabolic DiseasePeerVoice Clinical Pharmacology Video25:41Notes
    +Watch later
21. 21▶Silvia Stacchiotti, MD / Michiel van de Sande, MD, PhD - Surgical Interventions and Systemic Innovations: Collaborative Approaches to Tenosynovial Giant Cell Tumour as Pharmacological Advances EmergePeerVoice Oncology & Haematology Video18:45Notes
    +Watch later
22. 22▶Javier Cortés, MD, PhD / Laura Huppert, MD - Novel Uses for Trusted Tools: Investigational Approaches for TROP2-Directed ADCs in Advanced Breast CancerPeerVoice Oncology & Haematology Video19:41Notes
    +Watch later
23. 23▶David Alain Wohl, MD - From Guidelines to Ground Truth: The Reality of Rapid ART in the Real WorldPeerVoice Clinical Pharmacology Video20:43Notes
    +Watch later
24. 24▶Silvia Stacchiotti, MD / Michiel van de Sande, MD, PhD - Surgical Interventions and Systemic Innovations: Collaborative Approaches to Tenosynovial Giant Cell Tumour as Pharmacological Advances EmergePeerVoice Clinical Pharmacology Video18:45Notes
    +Watch later
25. 25▶Javier Cortés, MD, PhD / Laura Huppert, MD - Novel Uses for Trusted Tools: Investigational Approaches for TROP2-Directed ADCs in Advanced Breast CancerPeerVoice Clinical Pharmacology Video19:41Notes
    +Watch later
26. 26▶Marwan Fakih, MD - Making a Difference in Refractory Metastatic Colorectal Cancer: Practical Strategies to Positively Impact the Patient Journey Across Practice SettingsPeerVoice Oncology & Haematology Video28:23Notes
    +Watch later
27. 27▶Trisha Wise-Draper, MD, PhD - Beyond the Virus: New Strategies to Improve Outcomes of Non-HPV-Associated Recurrent/Metastatic Head and Neck CancerPeerVoice Oncology & Haematology Video54:23Notes
    +Watch later
28. 28▶Georgios Tsivgoulis, MD, PhD, MSc - Navigating the Latest Evidence Surrounding Current and Emerging Strategies for Secondary Stroke PreventionPeerVoice Brain & Behaviour Audio20:17Notes
    +Listen later
29. 29▶Silvia Messina, MD, DPhil / Michael Levy, MD, PhD - Myelin Oligodendrocyte Glycoprotein Antibody Disease (MOGAD) or Something Else? How to Tell the DifferencePeerVoice Brain & Behaviour Audio29:54Notes
    +Listen later
30. 30▶Georgios Tsivgoulis, MD, PhD, MSc - Navigating the Latest Evidence Surrounding Current and Emerging Strategies for Secondary Stroke PreventionPeerVoice Brain & Behaviour Video20:17Notes
    +Watch later
31. 31▶Silvia Messina, MD, DPhil / Michael Levy, MD, PhD - Myelin Oligodendrocyte Glycoprotein Antibody Disease (MOGAD) or Something Else? How to Tell the DifferencePeerVoice Brain & Behaviour Video29:54Notes
    +Watch later
32. 32▶Sven Francque, MD, PhD - The Gastroenterologist’s Guide to Finding and Managing MASH With Fibrosis: Practical Strategies for Everyday PracticePeerVoice Endocrinology & Metabolic Disorders Video35:42Notes
    +Watch later
33. 33▶Martin Köbel, MD - Scoring Folate Receptor-Alpha Expression in Gynecological Cancers: An Interactive Pathology MasterclassPeerVoice Oncology & Haematology Video29:59Notes
    +Watch later
34. 34▶Anjali Tiku Owens, MD - Contemporary Data, Differentiation, and Decision-Making in Hypertrophic Cardiomyopathy: A Guide to Cardiac Myosin Inhibition for the Managed Care ProfessionalPeerVoice Heart & Lung Video1:20:09Notes
    +Watch later
35. 35▶Mike Sharma, MD, MSc, FRCPC - Deepening the Dialogue on the Latest Data for Factor XIa Inhibition: Is It Time to Shift the Paradigm in Secondary Stroke Prevention?PeerVoice Brain & Behaviour Audio1:15:47Notes
    +Listen later
36. 36▶Mike Sharma, MD, MSc, FRCPC - Deepening the Dialogue on the Latest Data for Factor XIa Inhibition: Is It Time to Shift the Paradigm in Secondary Stroke Prevention?PeerVoice Brain & Behaviour Video1:15:47Notes
    +Watch later
37. 37▶Colin M. Dayan, MA, MBBS, FRCP, PhD - Innovation Through Immunomodulation: The Practicalities of Delaying the Progression of Type 1 DiabetesPeerVoice Endocrinology & Metabolic Disorders Video1:19:25Notes
    +Watch later
38. 38▶Javier Ampuero, MD, PhD - Making MASH a Priority in Our Gastroenterology Practices: Why We Should and How We CanPeerVoice Endocrinology & Metabolic Disorders Video20:02Notes
    +Watch later
39. 39▶Xin Cheng, MD, PhD - Seeking Solutions in Secondary Stroke Prevention: The Latest Inquiries and Insights on Factor XIa InhibitionPeerVoice Brain & Behaviour Audio36:53Notes
    +Listen later
40. 40▶Xin Cheng, MD, PhD - Seeking Solutions in Secondary Stroke Prevention: The Latest Inquiries and Insights on Factor XIa InhibitionPeerVoice Heart & Lung Video36:53Notes
    +Watch later
41. 41▶Xin Cheng, MD, PhD - Seeking Solutions in Secondary Stroke Prevention: The Latest Inquiries and Insights on Factor XIa InhibitionPeerVoice Brain & Behaviour Video36:53Notes
    +Watch later
42. 42▶Caterina Garone, MD, PhD - From Clinical Clues to a Confirmatory Diagnosis: Recognising Thymidine Kinase 2 Deficiency Across the Age SpectrumPeerVoice Brain & Behaviour Audio27:58Notes
    +Listen later
43. 43▶Caterina Garone, MD, PhD - From Clinical Clues to a Confirmatory Diagnosis: Recognising Thymidine Kinase 2 Deficiency Across the Age SpectrumPeerVoice Brain & Behaviour Video27:58Notes
    +Watch later
44. 44▶Pier Luigi Zinzani, MD, PhD - Recognising and Responding to a Rare Disease: A Case-Based Exploration of the Ideal iMCD Patient JourneyPeerVoice Oncology & Haematology Video20:07Notes
    +Watch later
45. 45▶Ashkan Shoamanesh, MD, FRCPC - Turning Pathophysiologic Promise Into Evidence-Based Potential: Are Factor XIa Inhibitors Ready for Prime Time in Secondary Stroke Prevention?PeerVoice Brain & Behaviour Audio1:10:40Notes
    +Listen later
46. 46▶Jonathan W. Goldman, MD / Misty Dawn Shields, MD, PhD - The Emerging Nuances of Extensive-Stage SCLC Treatment: Individualizing Care in the Immunotherapy EraPeerVoice Heart & Lung Video40:01Notes
    +Watch later
47. 47▶Ashkan Shoamanesh, MD, FRCPC - Turning Pathophysiologic Promise Into Evidence-Based Potential: Are Factor XIa Inhibitors Ready for Prime Time in Secondary Stroke Prevention?PeerVoice Brain & Behaviour Video1:10:40Notes
    +Watch later
48. 48▶Louise Moist, MD, MSc, CCPE / Peter J. Lin, MD, CCFP - Managing CKD With SGLT2 Inhibitors in Primary Care: Applying New Evidence Into Clinical PracticePeerVoice Endocrinology & Metabolic Disorders Video14:00Notes
    +Watch later
49. 49▶Louise Moist, MD, MSc, CCPE / Peter J. Lin, MD, CCFP - Managing CKD With SGLT2 Inhibitors in Primary Care: Applying New Evidence Into Clinical PracticePeerVoice Heart & Lung Video14:00Notes
    +Watch later
50. 50▶Melanie J. Davies, CBE, MBChB, MD, FMedSci / Linong Ji, MD - Managing the Cost of Type 2 Diabetes: The Impact of Effective Use of Established TherapiesPeerVoice Endocrinology & Metabolic Disorders Video21:51Notes
    +Watch later